These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17440061)

  • 1. Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.
    Roth P; Mittelbronn M; Wick W; Meyermann R; Tatagiba M; Weller M
    Cancer Res; 2007 Apr; 67(8):3540-4. PubMed ID: 17440061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
    Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
    Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
    Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
    Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
    Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
    Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
    Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.
    Germain C; Meier A; Jensen T; Knapnougel P; Poupon G; Lazzari A; Neisig A; Håkansson K; Dong T; Wagtmann N; Galsgaard ED; Spee P; Braud VM
    J Biol Chem; 2011 Nov; 286(44):37964-37975. PubMed ID: 21930700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF-15 contributes to proliferation and immune escape of malignant gliomas.
    Roth P; Junker M; Tritschler I; Mittelbronn M; Dombrowski Y; Breit SN; Tabatabai G; Wick W; Weller M; Wischhusen J
    Clin Cancer Res; 2010 Aug; 16(15):3851-9. PubMed ID: 20534737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
    Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
    Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
    Wischhusen J; Jung G; Radovanovic I; Beier C; Steinbach JP; Rimner A; Huang H; Schulz JB; Ohgaki H; Aguzzi A; Rammensee HG; Weller M
    Cancer Res; 2002 May; 62(9):2592-9. PubMed ID: 11980654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.
    Kita S; Matsubara H; Kasai Y; Tamaoki T; Okabe Y; Fukuhara H; Kamishikiryo J; Krayukhina E; Uchiyama S; Ose T; Kuroki K; Maenaka K
    Eur J Immunol; 2015 Jun; 45(6):1605-13. PubMed ID: 25826155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and purification of soluble and stable ectodomain of natural killer cell receptor LLT1 through high-density transfection of suspension adapted HEK293S GnTI(-) cells.
    Bláha J; Pachl P; Novák P; Vaněk O
    Protein Expr Purif; 2015 May; 109():7-13. PubMed ID: 25623399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
    Aldemir H; Prod'homme V; Dumaurier MJ; Retiere C; Poupon G; Cazareth J; Bihl F; Braud VM
    J Immunol; 2005 Dec; 175(12):7791-5. PubMed ID: 16339512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals.
    Tang M; Gao S; Zhang L; Liu B; Li J; Wang Z; Zhang W
    Prostate; 2020 Jul; 80(10):742-752. PubMed ID: 32449811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions.
    Bialoszewska A; Malejczyk J
    Crit Rev Immunol; 2018; 38(6):479-489. PubMed ID: 31002602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).
    Kamishikiryo J; Fukuhara H; Okabe Y; Kuroki K; Maenaka K
    J Biol Chem; 2011 Jul; 286(27):23823-30. PubMed ID: 21572041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
    Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
    Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion.
    Vivier E; Romagné F
    Immunity; 2007 May; 26(5):549-51. PubMed ID: 17521583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway.
    Bambard ND; Mathew SO; Mathew PA
    Scand J Immunol; 2010 Mar; 71(3):210-9. PubMed ID: 20415786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.
    Roth P; Aulwurm S; Gekel I; Beier D; Sperry RG; Mittelbronn M; Meyermann R; Beaman KD; Weller M; Wischhusen J
    Cancer Res; 2006 Apr; 66(7):3852-8. PubMed ID: 16585213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.